The  logo

Clinical Pharmacist (July/August 2010)

Clinical Pharmacist (July/August 2010)Clinical Pharmacist

CP 2010;2:233-270

July/August 2010

Other issues

Previous

Next

Back issues

Opinion

Raising the standards for pharmacy practice
D Rudkin
CP 2010;2:234

Editor’s choice
Score for patients, loss for the NHS
M Wright
CP 2010;2:234

 

Update

Bevacizumab data not fully applicable to NHS
CP 2010;2:235

Momentum builds for critical care accreditation
CP 2010;2:235

Dasatinib and nilotinib useful alternatives for CML
CP 2010;2:235

Rosiglitazone safety dilemma unclarified by new data
CP 2010;2:236

Debate continues over statins for primary prevention
CP 2010;2:236

Angiotensin-II receptor blockers could increase cancer risk
CP 2010;2:236

Combination of co-trimoxazole and renin/angiotensin drugs linked with hyperkalaemia
CP 2010;2:236

 

News feature

In the NHS a QIPP is no joke
F Rivers
CP 2010;2:238-239

 

Policy

Trends in NHS funding: individual funding requests
H Thorp, C Hughes
CP 2010;2:241-242

 

Clinical focus

Burns: clinical features and prognosis
N Rudall, A Green
CP 2010;2:245-248

Burns: management
A Green, N Rudall
CP 2010;2:249-254

Lifelong Learning
CP 2010;2:256

 

Learning light

Treatment of childhood bronchiolitis
D Cochrane
CP 2010;2:257-258

 

FAQ

A new mother is having trouble producing breast milk. What options are available to help?
CP 2010;2:260

 

Spotlight on medicines

Febuxostat
S Mercer
CP 2010;2:261-263

 

Consultant pharmacist

How independent prescribing can be nurtured in primary care
H Williams
CP 2010;2:264-266

 

Columnist

Reflections of an independent prescriber
We should not be afraid to discuss death
P Forsyth
CP 2010;2:266

 

Original paper

A report into the uptake of patient access schemes in the NHS
S Williamson, D Thomson
CP 2010;2:268-270

 

Supplement

UKCPA newsletter
July 2010
CP 2010;2:supplement